ClinicalTrials.Veeva

Menu

Ischemic Post-conditioning in Acute Ischemic Stroke Thrombectomy (PROTECT-1b)

C

Capital Medical University

Status and phase

Completed
Phase 2
Phase 1

Conditions

Acute Ischemic Stroke
Reperfusion Injury

Treatments

Procedure: Mechanical thrombectomy combined with ischemic post-conditioning

Study type

Interventional

Funder types

Other

Identifiers

NCT05909982
PROTECT-1b

Details and patient eligibility

About

Ischemic post-conditioning is a neuroprotective strategy attenuating reperfusion injury in animal stroke models. The investigators have conducted a 3 + 3 dose-escalation trial to demonstrate the safety and tolerability of ischemic post-conditioning incrementally for a longer duration of up to 5 min × 4 cycles in stroke patients undergoing mechanical thrombectomy. This study aims to assess the infarct volume after ischemic post-conditioning in patients with acute ischemic stroke who are treated with mechanical thrombectomy.

Enrollment

20 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years;
  • Acute ischemic stroke within 24 hours from stroke onset (or from time last known well) to groin puncture;
  • Previous mRS ≤ 2;
  • Baseline NIHSS ≥ 6;
  • Baseline ASPECTS ≥ 6;
  • With an occlusion of unilateral middle cerebral artery M1 segment/distal intracranial carotid artery;
  • Successful recanalization (mTICI ≥ 2b) after thrombectomy confirmed by DSA;
  • Written informed consent provided by the patients or their legal relatives.

Exclusion criteria

  • Confirmed or clinically suspected cerebral vasculitis/fibromuscular dysplasia;
  • Difficulty in reaching the designated position of the balloon used for ischemic post-conditioning;
  • Stenting in the middle cerebral artery M1 segment/distal intracranial carotid artery during thrombectomy;
  • > 2 times balloon dilations as rescue therapy due to angioplasty during thrombectomy;
  • Moderate/severe residual stenosis (≥ 50%) in the offending artery after thrombectomy;
  • Patients with contraindications to MRI;
  • Other conditions that the investigator considered inappropriate for inclusion.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

20 participants in 1 patient group

Ischemic post-conditioning group
Experimental group
Description:
Mechanical thrombectomy combined with ischemic post-conditioning
Treatment:
Procedure: Mechanical thrombectomy combined with ischemic post-conditioning

Trial contacts and locations

1

Loading...

Central trial contact

Xunming Ji, MD; Wenbo Zhao, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems